Michael Schweizer MDAssistant Professor, Division of Medical Oncology, University of Washington, Seattle, Washington
Michael Schweizer is an Assistant Professor at the University of Washington/Fred Hutchinson Cancer Research Center (UW/FHCRC) who specializes in genitourinary oncology. He received his medical degree from Temple University School of Medicine. Dr. Schweizer then went on to complete his internship and residency in internal medicine at the University of Chicago, and medical oncology fellowship at Johns Hopkins.
Dr. Schweizer is a clinical-translational researcher with a focus on early drug development for men with prostate cancer. He has been active in developing a number of novel prostate cancer therapies, including: high-dose testosterone for men with advanced prostate cancer and combination androgen ablative regimens for men with high-risk localized disease. By focusing on “high-risk, high-reward” projects, Dr. Schweizer hopes that his research will lead to new, effective therapies that will allow prostate cancer patients to live longer and better.